FDA NDC Directory · JSON-LD · Markdown
NDC 47335-758 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE
| Labeler / Manufacturer | Sun Pharmaceutical Industries, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA091272 |
| Dosage form / route | TABLET, EXTENDED RELEASE · ORAL |
| Active ingredients | VENLAFAXINE HYDROCHLORIDE (150 mg/1) |
| Marketing started | 20141215 |
| Package count | 6 |
Source: openFDA. Public-domain (CC0).